首页> 外文期刊>Annals of surgical oncology >Outcomes of total thyroidectomy with therapeutic central and lateral neck dissection with a single dose of radioiodine in the treatment of regionally advanced papillary thyroid cancer and effects on serum thyroglobulin
【24h】

Outcomes of total thyroidectomy with therapeutic central and lateral neck dissection with a single dose of radioiodine in the treatment of regionally advanced papillary thyroid cancer and effects on serum thyroglobulin

机译:全剂量甲状腺切除术联合单剂量放射性碘治疗中央和外侧颈清扫术对局部晚期甲状腺乳头状癌的治疗及其对血清甲状腺球蛋白的影响

获取原文
获取原文并翻译 | 示例

摘要

Background: Achieving an undetectable serum thyroglobulin (Tg) level (<1.0 ng/mL) after surgical and radioiodine treatment for papillary thyroid cancer (PTC) is associated with low recurrence rates and has been termed biochemical remission. This study aimed to determine the effectiveness of total thyroidectomy with therapeutic central and lateral neck dissection for regionally advanced (T1-4bN1bM0) PTC with regard to posttreatment Tg levels. Methods: This is a single-institution retrospective cohort study of patients with regionally advanced PTC initially treated with total thyroidectomy and therapeutic levels 2-7 neck dissection from 2002 to 2012. Pathologic findings, complications, serum Tg levels, and outcomes were analyzed. Results: Sixty-one patients were initially treated with total thyroidectomy and therapeutic central and lateral neck dissection for PTC involving the lateral cervical nodes (N1b). The median number of lymph nodes excised and positive was 27 (range 5-112) and 9 (range 1-67), respectively. Extranodal extension occurred in 48 %. Radioiodine was administered after surgery with a median total dose of 150 mCi (range 30-244 mCi). Recurrent or persistent cervical disease occurred in 8 (13 %) and 3 (5 %) patients, respectively, and required additional radioiodine treatment in 2 and reoperative neck dissection in 10. Three patients developed new distant metastasis, and 1 died during the median follow-up of 20 months (range 1-109 months). Undetectable unstimulated Tg (<1.0 ng/mL) without clinically detectable recurrence was experienced in 68 % of patients with initial treatment. Conclusions: Biochemical remission can be experienced in most patients presenting with regionally advanced PTC with total thyroidectomy and compartment based therapeutic neck dissection followed by a single dose of radioiodine.
机译:背景:甲状腺乳头状癌(PTC)的手术和放射性碘治疗后,血清甲状腺球蛋白(Tg)水平达不到(<1.0 ng / mL)与低复发率相关,被称为生化缓解。这项研究旨在确定就治疗后的Tg水平而言,对区域晚期(T1-4bN1bM0)PTC进行治疗性中央和外侧颈全切术的全甲状腺切除术的有效性。方法:这是一项单机构回顾性队列研究,研究对象为2002年至2012年间接受全甲状腺切除术且治疗水平为2-7颈清扫术的局部晚期PTC患者。对病理结果,并发症,血清Tg水平和结局进行了分析。结果:61例患者最初接受了全甲状腺切除术,并经治疗性中央和外侧颈淋巴结清扫术累及了颈外侧结(N1b)。切除淋巴结和阳性淋巴结的中位数分别为27(5-112)和9(1-67)。结外扩展发生率为48%。手术后给予放射性碘,中位总剂量为150 mCi(范围为30-244 mCi)。复发或持续性宫颈疾病分别发生在8(13%)和3(5%)的患者中,其中2例需要额外的放射性碘治疗,10例行颈清扫术。3例发生新的远处转移,其中1例在中位随访期间死亡-20个月(范围1-109个月)。 68%的初始治疗患者经历了无法检测到的未刺激Tg(<1.0 ng / mL),而没有临床可检测到的复发。结论:大多数表现为局部晚期PTC并行全甲状腺切除术和基于隔室的治疗性颈清扫术,然后单剂量放射性碘的患者,可发生生化缓解。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号